| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. | HEAD OF R&D | Stock Options (Right to Buy) | 30,000 | 25 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923007510-modur-vijay-2023-01-25 | Eloxx Pharmaceuticals, Inc. | 25 Jan 2023 | 1 | $0 | 4 | HEAD OF R&D | 27 Jan 2023, 15:02 |
| /report/000141588921005692-modur-vijay-2021-12-01 | Eloxx Pharmaceuticals, Inc. | 01 Dec 2021 | 3 | -$46,349 | 4 | HEAD OF R&D | 03 Dec 2021, 16:14 |
| /report/000141588921002555-modur-vijay-2021-05-18 | Eloxx Pharmaceuticals, Inc. | 18 May 2021 | 1 | $0 | 4 | HEAD OF R&D | 18 May 2021, 17:48 |